Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2

BACKGROUND: Next-generation sequencing (NGS) has proven to be a key implementation to understanding biological pathways involved in cancer. In daily practice, the identification of somatic and germline mutations has allowed physicians to gather relevant information to make therapeutic decisions and...

Descripción completa

Detalles Bibliográficos
Autores principales: Narváez, Dana, Waisberg, Federico, Soulé, Tomás, Angel, Martín, Bruno, Luisina, Girotti, Maria Romina, Pupareli, Carmen, Chacón, Matías, Petracci, Fernando E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666283/
https://www.ncbi.nlm.nih.gov/pubmed/36405946
http://dx.doi.org/10.3332/ecancer.2022.1448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666283/
https://www.ncbi.nlm.nih.gov/pubmed/36405946
http://dx.doi.org/10.3332/ecancer.2022.1448

Ejemplares similares